Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma

The objective of this study was to evaluate the feasibility of developing personalized, tumor-informed assays for patients with high-risk resectable melanoma and examine circulating tumor DNA (ctDNA) levels in relation to clinical status. Pilot prospective study of clinical stage IIB/C and resectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunsgaard, Elise K., Bowles, Tawnya L., Asare, Elliot A., Grossmann, Kenneth, Boucher, Kenneth M., Grossmann, Allie, Jackson, Julie A., Wada, David A., Rathore, Richa, Budde, Griffin, Grandemange, Andrew, Hyngstrom, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144272/
https://www.ncbi.nlm.nih.gov/pubmed/37040662
http://dx.doi.org/10.1097/CMR.0000000000000892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144272/
https://www.ncbi.nlm.nih.gov/pubmed/37040662
http://dx.doi.org/10.1097/CMR.0000000000000892

Ejemplares similares